TimeZone (America/Los Angeles)
Treating Melanoma with Immunotherapy
Tuesday, June 18, 2013 11:00:00 AM PDT - 11:45:00 AM PDT
Dr. Jedd D. Wolchok is a medical oncologist who specializes in the treatment of melanoma at Memorial Sloan-Kettering Cancer Center, and whose research focuses on the development of innovative ways to use the immune system to treat cancer. He has been at the forefront of cancer immunotherapy, as an active clinician scientist exploring immunotherapy and as a principal investigator in several pivotal clinical trials, including a large phase III trial that led to the FDA approval of ipilimumab, an antibody now used as a first-line treatment for patients with advanced melanoma. He will discuss current advances in cancer immunotherapy for melanoma and other cancers.


Jedd D. Wolchok, M.D., Ph.D.
Jedd D. Wolchok, M.D., Ph.D., is the director of Immunotherapy Clinical Trials, an associate attending physician in melanoma-sarcoma, is head of the Swim Across America Laboratory, and an associate director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. He is also the associate chair of medicine and leads the Immunotherapeutics Clinical Core at MSKCC.

If you've never used Adobe Connect, get a quick overview: http://www.adobe.com/products/adobeconnect.html
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks
of Adobe Systems Incorporated in the United States and/or other countries.